Skip to content

Author

A. Borozinets

We have 1 of 16 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

RESULTS OF A PROSPECTIVE MULTICENTER OPEN-LABEL OBSERVATIONAL STUDY OF ENZYME REPLACEMENT THERAPY WITH AN IMIGLUCERASE BIOSIMILAR IN CHILDREN WITH TYPE 1 GAUCHER DISEASE

Enzyme replacement therapy (ERT) is the mainstay for type 1 Gaucher disease (GD1) treatment. Imiglucerase biosimilar usage allows to control GD1 manifestations and improve the patients’ life quality according to interventional clinical studies. Objective: To evaluate the results of Glurazyme® use during long-term ERT i...

G. Movsisyan, A. S. Potapov, Y. Dinikina et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.